Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 for prevention of cisplatin-induced nephrotoxicity
IRCT20211205053287N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of coenzyme q10 in nephrotoxicity, sponsored by Shahrekord University of Medical Sciences. Started Apr 2022; status: completed.
02
Drugs
coenzyme q10
03
Conditions
nephrotoxicity
Beyond the preview
Go deeper on IRCT20211205053287N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211205053287N1.